| 000 | 01476 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513124001.0 | ||
| 264 | 0 | _c19971014 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a0302-282X | ||
| 024 | 7 |
_a10.1159/000119365 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeszaros, K | |
| 245 | 0 | 0 |
_aBiperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients. _h[electronic resource] |
| 260 |
_bNeuropsychobiology _c1997 |
||
| 300 |
_a69-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Dyskinesia Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xblood |
| 650 | 0 | 4 |
_aBiperiden _xadministration & dosage |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHaloperidol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aSchizophrenia _xcomplications |
| 700 | 1 | _aLenzinger, E | |
| 700 | 1 | _aHornik, K | |
| 700 | 1 | _aSchönbeck, G | |
| 700 | 1 | _aHatzinger, R | |
| 700 | 1 | _aLanger, G | |
| 700 | 1 | _aSieghart, W | |
| 700 | 1 | _aAschauer, H N | |
| 773 | 0 |
_tNeuropsychobiology _gvol. 36 _gno. 2 _gp. 69-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000119365 _zAvailable from publisher's website |
| 999 |
_c9247435 _d9247435 |
||